Francis Chu

1.9k total citations · 1 hit paper
31 papers, 1.3k citations indexed

About

Francis Chu is a scholar working on Surgery, Oncology and Hepatology. According to data from OpenAlex, Francis Chu has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 17 papers in Oncology and 17 papers in Hepatology. Recurrent topics in Francis Chu's work include Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers) and Colorectal Cancer Treatments and Studies (10 papers). Francis Chu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers) and Colorectal Cancer Treatments and Studies (10 papers). Francis Chu collaborates with scholars based in Australia, India and United Kingdom. Francis Chu's co-authors include David L. Morris, Terence C. Chua, Akshat Saxena, Winston Liauw, Lourens Bester, Tristan D. Yan, Deborah Black, Marlon Perera, Amany Zekry and Jason Behary and has published in prestigious journals such as Nature Communications, Cancer and European Journal of Cancer.

In The Last Decade

Francis Chu

31 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma

2021 331 citations Jason Behary, Nadia Amorim et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Francis Chu Australia	19	681	512	468	439	376	31	1.3k
François‐Xavier Caroli‐Bosc France	23	629 0.9×	231 0.5×	780 1.7×	356 0.8×	642 1.7×	85	1.6k
Wenzel Schöning Germany	21	287 0.4×	734 1.4×	810 1.7×	274 0.6×	260 0.7×	117	1.4k
I‐Cheng Lee Taiwan	20	285 0.4×	700 1.4×	128 0.3×	557 1.3×	128 0.3×	57	1.1k
Philippe Wolf France	22	358 0.5×	825 1.6×	566 1.2×	468 1.1×	146 0.4×	44	1.3k
Florian Primavesi Austria	17	314 0.5×	211 0.4×	334 0.7×	169 0.4×	166 0.4×	61	740
Chuan Li China	20	344 0.5×	743 1.5×	404 0.9×	460 1.0×	182 0.5×	97	1.3k
Viniyendra Pamecha India	20	282 0.4×	837 1.6×	729 1.6×	374 0.9×	115 0.3×	95	1.2k
Glenn Kunnath Bonney Singapore	17	284 0.4×	391 0.8×	439 0.9×	202 0.5×	127 0.3×	60	847
Judith I. Wyatt United Kingdom	15	203 0.3×	568 1.1×	546 1.2×	542 1.2×	209 0.6×	26	1.3k

Countries citing papers authored by Francis Chu

Since Specialization

Citations

This map shows the geographic impact of Francis Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis Chu more than expected).

Fields of papers citing papers by Francis Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francis Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis Chu. The network helps show where Francis Chu may publish in the future.

Co-authorship network of co-authors of Francis Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Francis Chu. A scholar is included among the top collaborators of Francis Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francis Chu. Francis Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zandavi, Seid Miad, Thomas Goodwin, Ammar Majeed, et al.. (2024). AI‐powered prediction of HCC recurrence after surgical resection: Personalised intervention opportunities using patient‐specific risk factors. Liver International. 44(10). 2724–2737. 7 indexed citations

Behary, Jason, Nadia Amorim, Xiaotao Jiang, et al.. (2021). Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma. Nature Communications. 12(1). 187–187. 331 indexed citations breakdown →

Saxena, Akshat, Terence C. Chua, Marlon Perera, Francis Chu, & David L. Morris. (2012). Surgical resection of hepatic metastases from neuroendocrine neoplasms: A systematic review. Surgical Oncology. 21(3). e131–e141. 99 indexed citations

Chua, Terence C., Winston Liauw, Francis Chu, & David L. Morris. (2012). Viewing Metastatic Colorectal Cancer as a Curable Chronic Disease. American Journal of Clinical Oncology. 35(1). 77–80. 33 indexed citations

Chua, Terence C., Winston Liauw, Francis Chu, & David L. Morris. (2012). Summary outcomes of two‐stage resection for advanced colorectal liver metastases. Journal of Surgical Oncology. 107(2). 211–216. 33 indexed citations

Saxena, Akshat, Terence C. Chua, Francis Chu, & David L. Morris. (2011). Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival. The American Journal of Surgery. 202(3). 310–320. 63 indexed citations

Chua, Terence C., Akshat Saxena, Francis Chu, Jing Zhao, & David L. Morris. (2011). Predictors of cure after hepatic resection of colorectal liver metastases: An analysis of actual 5‐ and 10‐year survivors. Journal of Surgical Oncology. 103(8). 796–800. 50 indexed citations

Chua, Terence C., et al.. (2011). Two Decades of Experience with Hepatic Cryotherapy for Advanced Colorectal Metastases. Annals of Surgical Oncology. 19(4). 1276–1283. 24 indexed citations

Saxena, Akshat, et al.. (2011). Optimizing the Surgical Effort in Patients With Advanced Neuroendocrine Neoplasm Hepatic Metastases. American Journal of Clinical Oncology. 35(5). 439–445. 13 indexed citations

10.

Chua, Terence C., Akshat Saxena, Winston Liauw, Francis Chu, & David L. Morris. (2011). Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases – A systematic review. European Journal of Cancer. 48(12). 1757–1765. 46 indexed citations

11.

Chua, Terence C., Akshat Saxena, Francis Chu, & David L. Morris. (2011). Hepatic Resection for Transplantable Hepatocellular Carcinoma for Patients Within Milan and UCSF Criteria. American Journal of Clinical Oncology. 35(2). 141–145. 8 indexed citations

12.

Chua, Terence C., Francis Chu, S. P. Butler, et al.. (2010). Intra‐arterial iodine‐131‐lipiodol for unresectable hepatocellular carcinoma. Cancer. 116(17). 4069–4077. 20 indexed citations

13.

Chua, Terence C., Francis Chu, & David L. Morris. (2010). Outcomes of Single-Centre Experience of Hepatic Resection and Cryoablation of Sarcoma Liver Metastases. American Journal of Clinical Oncology. 34(3). 317–320. 10 indexed citations

14.

Chua, Terence C., Akshat Saxena, Francis Chu, et al.. (2010). Clinicopathological Determinants of Survival After Hepatic Resection of Hepatocellular Carcinoma in 97 Patients—Experience From an Australian Hepatobiliary Unit. Journal of Gastrointestinal Surgery. 14(9). 1370–1380. 11 indexed citations

15.

Chua, Terence C., Akshat Saxena, Francis Chu, et al.. (2010). Hepatic resection with or without adjuvant iodine-131-lipiodol for hepatocellular carcinoma: a comparative analysis. International Journal of Clinical Oncology. 16(2). 125–132. 15 indexed citations

16.

Saxena, Akshat, et al.. (2010). Clinicopathologic and Treatment-Related Factors Influencing Recurrence and Survival after Hepatic Resection of Intrahepatic Cholangiocarcinoma: A 19-Year Experience from an Established Australian Hepatobiliary Unit. Journal of Gastrointestinal Surgery. 14(7). 1128–1138. 52 indexed citations

17.

Yan, Tristan D., et al.. (2009). Prognostic determinants for survival after resection/ablation of a large hepatocellular carcinoma. HPB. 11(4). 311–320. 28 indexed citations

18.

Chua, Terence C., Winston Liauw, Akshat Saxena, et al.. (2009). Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma. Liver International. 30(2). 166–174. 57 indexed citations

19.

Saxena, Akshat, Lourens Bester, Terence C. Chua, Francis Chu, & David L. Morris. (2009). Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of This Novel Treatment Option. Annals of Surgical Oncology. 17(2). 484–491. 143 indexed citations

20.

Chu, Francis, et al.. (2007). The effects of surgical margin and edge cryotherapy after liver resection for colorectal cancer metastases. HPB. 9(3). 201–207. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact